Media Room

  • Virax Biolabs' CEO James Foster Issues Letter to Shareholders

    2 February 2023
    Virax Biolabs, Press Release

    read article

  • Virax Biolabs Introduces Human Papillomavirus ("HPV") Test Kit

    4 January 2023
    Virax Biolabs, Press Release

    read article

  • Determining Long Term Immunity May Aid in Understanding Vaccine Efficacy – Interview with Dr. Tomasz George, CSO

    22 December 2022
    John Parkinson, Contagion Live

    read article

  • Virax Biolabs Preparing T-Cell Testing Platform to Provide Consumers With Immune Status Info

    16 December 2022
    Kelsy Ketchum, 360 Dx

    read article

  • COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States

    6 December 2022
    Virax Biolabs, Press Release

    read article

  • Assessing Adaptive Immune Responses to Viruses to Inform Decisions about Vaccinations with Dr. Tomasz George

    1 December 2022
    Karen Jagoda, Empowered Patient Podcast

    read article

  • In Every Crisis There Is An Opportunity – Interview with Chief Executive, James Foster

    23 November 2022
    Tom Hickey, Med Tech Gurus

    read article

  • Virax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales

    15 November 2022
    Virax Biolabs, Press Release

    read article

  • Virax Biolabs Announces Closing of $3.8 Million Private Placement

    8 November 2022
    Virax Biolabs, Press Releases

    read article

  • Virax Biolabs Announces $3.8 Million Private Placement

    4 November 2022
    Virax Biolabs, Press Release

    read article

  • Virax Biolabs Introduces RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit

    3 November 2022
    Virax Biolabs, Press Releases

    read article

  • Virax Biolabs Announces Initiation of its Virax Immune COVID-19 Analytical Performance Study

    26 October 2022
    Virax Biolabs, Press Releases

    read article

  • Monkeypox Diagnosis and Immune Profiling Using Proprietary T-cell Test Technology

    30 September 2022
    Radio Interview, Health Professional Radio

    read article

  • Virax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc.

    22 September 2022
    Virax Biolabs, Press Releases

    read article

  • Virax Biolabs Introduces Monkeypox Virus Antigen Rapid Test Kit

    20 September 2022
    Virax Biolabs, Press Releases

    read article

  • Virax BioLabs Presents at H.C. Wainwright's 24th Annual Global Investment Conference

    12 September 2022
    Virax Biolabs, Press Releases

    read article

  • Virax Biolabs Group Limited to Present at H.C. Wainwright's 24th Annual Global Investment Conference in New York, NY

    6 September 2022
    Virax Biolabs, Press Releases

    read article

  • Virax Biolabs Announces NASDAQ Closing Bell Ringing to Celebrate Initial Public Offering

    16 August 2022
    Virax Biolabs, Press Releases

    read article

  • Benzinga Interview with Chief Executive, James Foster

    4 August 2022
    Video Interview, Benzinga

    read article

  • Virax Biolabs Introduces Monkeypox and Varicella-Zoster Viruses Real-Time PCR Detection Kit

    26 July 2022
    Virax Biolabs, Press Releases

    read article

  • Virax Biolabs Bucks the Market Trend

    26 July 2022
    Video Interview, Proactive

    read article

  • Virax Biolabs Group Limited Completes Initial Public Offering; Shares Begin Trading Today on NASDAQ Capital Market as VRAX

    21 July 2022
    Virax Biolabs, Press Releases

    read article

  • Virax Biolabs Group Limited Announces Pricing of $6.75 Million Initial Public Offering

    20 July 2022
    Virax Biolabs, Press Releases

    read article

  • Virax Biolabs Announces the Formation of Advisory Board of Industry Leaders

    31 May 2022
    Virax Biolabs, Press Releases

    read article

  • Virax Biolabs Introduces New Board of Directors, Announces Members

    17 May 2022
    Virax Biolabs, Press Releases

    read article

  • Virax Biolabs Receives Ethical Approval for its Virax Immune COVID-19 Analytical Performance Study from the SBEBO Foundation for the Assessment of Ethics of Biomedical Research

    9 May 2022
    Virax Biolabs, GlobeNewswire

    read article

  • Virax Biolabs Announces the Appointment of Jason D. Davis as Chief Financial Officer

    28 April 2022
    Virax Biolabs, Press Release

    read article

  • Common cold may protect against SARS-CoV-2 infection and lead the way to new vaccines

    14 January 2022
    Katharine Lang, Medical News Today

    read article

  • EXPLAINED: You May Never Forget The Omicron Variant, Here's Why Your T Cells Certainly Won't Anytime Soon

    31 December 2021
    Kenneth Mohanty, News 18

    read article

  • Beyond the spike: Are T cell COVID-19 vaccines the future?

    20 December 2021
    Debbie Lambert, Medical News Today

    read article

  • Sales of PPE in the UK overtake sandwiches with the masks and hand sanitiser industry now worth more than £8.7BILLION

    21 September 2020
    Jack Elsom, Daily Mail

    read article

  • Coronavirus warning: The 5 most likely places to catch coronavirus in an office

    9 September 2020
    Georgina Laud, Express

    read article

  • Experts reveal ‘Covid hotspots’ in the office – and how to limit your risk

    7 September 2020
    Natalie Morris, Metro

    read article

  • Face coverings to be made compulsory on public transport in England

    4 June 2020
    Rowena Mason, The Guardian

    read article